GENFLEET-B (02595): A total of 872,000 H shares repurchased as of September 18
GenFleet Therapeutics-B (02595) announced that as of September 18, 2026, the Company conducted a series of H share repurchases on The Stock Exchange of Hong Kong Limited, repurchasing a total of 872,000 H shares, representing approximately 0.227% of the Company's total issued share capital as of the date of this announcement. The Company may assess market conditions and continue to implement its 2026 H share repurchase plan.
GENFLEET-B (02595) announced that as of September 18, 2026, the company conducted a series of H share repurchases on The Stock Exchange of Hong Kong Limited, repurchasing a total of 872,000 H shares, representing approximately 0.227% of the company's total issued share capital as of the date of this announcement. The company may assess market conditions and continue to implement its 2026 H share repurchase plan.
Related Articles
HANSOH PHARMA (03692): Phase III clinical study of HS-10374 for the treatment of moderate-to-severe plaque psoriasis met the co-primary endpoints.
BJ DIGITAL(06188) subsidiary enters into factoring financing agreement
VOBILE GROUP (03738): Official Launch of SeeBay, a One-Stop Industry Platform for "AI Content Creation + IP Assetization and Global Monetization"
HANSOH PHARMA (03692): Phase III clinical study of HS-10374 for the treatment of moderate-to-severe plaque psoriasis met the co-primary endpoints.
BJ DIGITAL(06188) subsidiary enters into factoring financing agreement
VOBILE GROUP (03738): Official Launch of SeeBay, a One-Stop Industry Platform for "AI Content Creation + IP Assetization and Global Monetization"
RECOMMEND
